|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q3 FY2020
As of Sep 30, 2020
|
Q2 FY2020
As of Jun 30, 2020
|
Q1 FY2020
As of Mar 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q3 FY2019
As of Sep 30, 2019
|
Q2 FY2019
As of Jun 30, 2019
|
Q1 FY2019
As of Mar 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Receivables from service providers | ||||||||||||||||||||
| Short-term investments | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Fiduciary funds - restricted | ||||||||||||||||||||
| Trade accounts receivable, less allowances of $13,971 and $18,167, respectively | ||||||||||||||||||||
| Other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Right-of-use assets | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Intangibles, net | ||||||||||||||||||||
| Indefinite-lived intangibles | ||||||||||||||||||||
| Capitalized software development costs, net | ||||||||||||||||||||
| Non Current Accounts receivable, less allowance | ||||||||||||||||||||
| Deferred tax asset, net | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable and accrued liabilities | ||||||||||||||||||||
| Payables to service agents | ||||||||||||||||||||
| Accrued payroll and related benefits | ||||||||||||||||||||
| Working capital facility | ||||||||||||||||||||
| Fiduciary funds - restricted | ||||||||||||||||||||
| Contingent liability for earn-out acquisition consideration | ||||||||||||||||||||
| Revolving line of credit | ||||||||||||||||||||
| Short-term debt | ||||||||||||||||||||
| Current portion of long term debt and financing lease obligations, net of deferred financing costs of $3,287 and $469, respectively | ||||||||||||||||||||
| Contract liabilities | ||||||||||||||||||||
| Lease liability | ||||||||||||||||||||
| Other current liabilities | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Revolving line of credit | ||||||||||||||||||||
| Long term debt and financing lease obligations, less current portion, net of deferred financing costs of $0 and $261, respectively | ||||||||||||||||||||
| Contingent liability for earn-out acquisition consideration | ||||||||||||||||||||
| Long term debt and financing lease obligations, less current portion, net of deferred financing costs of $0 and $0, respectively | ||||||||||||||||||||
| Contingent liability for accrued earn-out acquisition consideration | ||||||||||||||||||||
| Contract liabilities | ||||||||||||||||||||
| Lease liability | ||||||||||||||||||||
| Deferred tax liability, net | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders’ equity: | ||||||||||||||||||||
| Preferred stock, $0.10 par value, 500,000 shares authorized, no shares issued and outstanding at September 30, 2023 and December 31, 2022 | ||||||||||||||||||||
| Preferred Stock | ||||||||||||||||||||
| Total preferred stock, $0.10 par value, 500,000 shares authorized, no shares issued and outstanding at September 30, 2023 and December 31, 2022 | ||||||||||||||||||||
| Series Y Convertible preferred stock, $0.10 par value, 350,000 shares authorized, no shares issued and outstanding at September 30, 2023 and December 31, 2022 | ||||||||||||||||||||
| Series Y Convertible preferred stock | ||||||||||||||||||||
| Total series Y Convertible preferred stock, $0.10 par value, 350,000 shares authorized, no shares issued and outstanding at September 30, 2023 and December 31, 2022 | ||||||||||||||||||||
| Common stock, $0.10 par value, 220,000,000 shares authorized, 30,899,335 issued and outstanding, at September 30, 2023, and 30,819,533 issued and outstanding at December 31, 2022 | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Total Ebix, Inc. stockholders’ equity | ||||||||||||||||||||
| Noncontrolling interest | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Total liabilities and stockholders’ equity | ||||||||||||||||||||
Loading...